Nutrastar International Revenue Growth Rates (NUIN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nutrastar International Inc.  (NUIN)
 

NUIN's Revenue Growth by Quarter and Year

Nutrastar International's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUIN Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September 11.02
2nd Quarter June 13.24
1st Quarter March 7.04
FY 31.30





NUIN Revenue third quarter 2015 Y/Y Growth Comment
Nutrastar International Inc. reported decrease in Revenue in the third quarter 2015 by -1.27% to $ 11.02 millions, from the same quarter in 2014.
The decrease in the third quarter 2015 Nutrastar International Inc.'s Revenue compares unfavorably to the Company's average Revenue increase of 12.09%.

Looking into third quarter 2015 results within Biotechnology & Pharmaceuticals industry 34 other companies have achieved higher Revenue growth. While Nutrastar International Inc.' s Revenue decline of -1.27% ranks overall at the positon no. 2522 in the third quarter 2015.


NUIN Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - -6.4 % 6.75 % 10.12 %
3rd Quarter September -1.27 % 2.01 % 44.52 % -20.82 %
2nd Quarter June 1.85 % 9.52 % 18.23 % 30.73 %
1st Quarter March 2.47 % -7.29 % 8.02 % 18.28 %
FY   - -0.07 % 17.9 % -

Financial Statements
Nutrastar International's third quarter 2015 Revenue $ 11.02 millions NUIN's Income Statement
Nutrastar International's third quarter 2014 Revenue $ 11.16 millions Quarterly NUIN's Income Statement


NUIN Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - 10.13 % 20.02 % 62.48 %
3rd Quarter September -16.78 % -14.15 % -7.83 % -24.6 %
2nd Quarter June 88.07 % 89.23 % 60.19 % 46.36 %
1st Quarter March -42.72 % -47.68 % -39.76 % -38.59 %
FY (Year on Year)   - -0.07 % 17.9 % -


Back to NUIN Growth rate Comparisons >> Back to NUIN Growth rate Comparisons >>


Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #35
Healthcare Sector #333
Overall #2522

Revenue Y/Y Growth Statistics
High Average Low
47.93 % 12.09 % -20.78 %
(Sep 30 2013)   (Mar 31 2014)
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #35
Healthcare Sector #333
Overall #2522
Revenue Y/Y Growth Statistics
High Average Low
47.93 % 12.09 % -20.78 %
(Sep 30 2013)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Nutrastar International's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
89.39 % 13.07 % -47.69 %
(Jun 30 2014)  


NUIN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Nutrastar International Inc. disclosed fall in Revenue from the second quarter by -16.78% to $ 11.02 millions, from $ 13.24 millions achived in the previous reporting period.

But that's not important problem, as Nutrastar International's Revenue generally seem to plunge in this quarter.

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Nutrastar International's Revenue growth quarter on quarter, overall rank is 3520.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #431
Overall #3520
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #431
Overall #3520
Revenue Q/Q Growth Statistics
High Average Low
89.39 % 13.07 % -47.69 %
(Jun 30 2014)  


NUIN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Nutrastar International Inc. disclosed fall in Revenue from the second quarter by -16.78% to $ 11.02 millions, from $ 13.24 millions achived in the previous reporting period.

But that's not important problem, as Nutrastar International's Revenue generally seem to plunge in this quarter.

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Nutrastar International's Revenue growth quarter on quarter, overall rank is 3520.


Nutrastar International's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2015)		 12 Months Ending
(Jun 30 2015)		 12 Months Ending
(Mar 31 2015)		 12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Sep 30 2014)
Cumulative Revenue 12 Months Ending $ 43.60 $ 43.74 $ 43.50 $ 43.33 $ 44.16
Y / Y Revenue Growth (TTM) -1.29 % -0.44 % 1.63 % -0.05 % 3.86 %
Year on Year Revenue Growth Overall Ranking # 2192 # 2459 # 2455 # 2455 # 841
Seqeuential Revenue Change (TTM) -0.33 % 0.55 % 0.41 % -1.89 % 0.52 %
Seq. Revenue Growth (TTM) Overall Ranking # 1940 # 2594 # 0 # 0 # 1897


Cumulative Revenue growth Comment
Nutrastar International's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.29% year on year, at Sep 30 2015 compare to the -0.44% decrease at Jun 30 2015. If the Nutrastar International's fiscal year would end at Sep 30 2015, annual Revenue would be $44 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2192, from total ranking in previous quarter at 2459.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 279
Overall # 2192

Revenue TTM Y/Y Growth Statistics
High Average Low
17.89 %
 6.06 %
-1.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 259
S&P 500 # 1940
Cumulative Revenue growth Comment
Nutrastar International's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.29% year on year, at Sep 30 2015 compare to the -0.44% decrease at Jun 30 2015. If the Nutrastar International's fiscal year would end at Sep 30 2015, annual Revenue would be $44 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2192, from total ranking in previous quarter at 2459.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 279
Overall # 2192

Revenue TTM Y/Y Growth Statistics
High Average Low
17.89 %
6.06 %
-1.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 26
Sector # 259
S&P 500 # 1940




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NUIN's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2015
Intercept Pharmaceuticals inc -0.09%$ -0.091 millions
Rafina Innovations Inc.-0.13%$ -0.131 millions
Phibro Animal Health Corporation-0.18%$ -0.180 millions
Arqule Inc-0.34%$ -0.338 millions
Msa Safety Inc-0.57%$ -0.568 millions
Achaogen, Inc.-0.97%$ -0.973 millions
Quest Diagnostics Inc-1.26%$ -1.261 millions
Nutrastar International Inc.-1.31%$ -1.312 millions
Integra Lifesciences Holdings Corp-1.46%$ -1.459 millions
Cyteir Therapeutics Inc -1.87%$ -1.875 millions
Lantheus Holdings Inc -2.06%$ -2.060 millions
Fonar Corporation-2.08%$ -2.080 millions
Pfizer Inc-2.22%$ -2.217 millions
Endo International Plc-2.38%$ -2.384 millions
American Shared Hospital Services-2.69%$ -2.687 millions
Bio Green Med Solution Inc -2.72%$ -2.721 millions
Ufp Technologies Inc -2.73%$ -2.726 millions
Seaspine Holdings Corporation-2.76%$ -2.758 millions
Natera Inc -2.92%$ -2.924 millions
Igc Pharma Inc -2.94%$ -2.938 millions
Teleflex Incorporated-2.94%$ -2.944 millions
Milestone Scientific Inc -2.96%$ -2.964 millions
West Pharmaceutical Services Inc -3.20%$ -3.203 millions
Conmed Corporation-3.30%$ -3.302 millions
Five Prime Therapeutics Inc -3.32%$ -3.317 millions
Standard Biotools Inc -3.35%$ -3.347 millions
Haemonetics Corporation-3.47%$ -3.466 millions
U s Stem Cell Inc -3.78%$ -3.783 millions
Mettler toledo International Inc -3.97%$ -3.965 millions
Allied Healthcare Products inc -4.32%$ -4.324 millions


About Nutrastar International Revenue Growth Rates (NUIN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.